The role of aldosterone in the pathogenesis of diabetic retinopathy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of aldosterone in the pathogenesis of diabetic retinopathy
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 14, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2023-04-11
DOI
10.3389/fendo.2023.1163787
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advanced Glycation End-Products and Diabetic Neuropathy of the Retina
- (2023) Toshiyuki Oshitari INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Finerenone, a Non-Steroidal Mineralocorticoid Receptor Antagonist, Reduces Vascular Injury and Increases Regulatory T-Cells: Studies in Rodents with Diabetic and Neovascular Retinopathy
- (2023) Jack R. Jerome et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Investigation of angiotensin-1 converting enzyme 2 gene (G8790A) polymorphism in patients of type 2 diabetes mellitus with diabetic nephropathy in Pakistani population
- (2022) Hooria Younas et al. PLoS One
- The mineralocorticoid receptor signal could be a new molecular target for the treatment of diabetic retinal complication
- (2022) Kennosuke Ohashi et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Primary Aldosteronism and Resistant Hypertension: A Pathophysiological Insight
- (2022) Fabio Bioletto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeted P2X7/NLRP3 signaling pathway against inflammation, apoptosis, and pyroptosis of retinal endothelial cells in diabetic retinopathy
- (2022) Hui Kong et al. Cell Death & Disease
- Stress Hormones Cortisol and Aldosterone, and Selected Markers of Oxidative Stress in Response to Long-Term Supplementation with Omega-3 Fatty Acids in Adolescent Children with Depression
- (2022) Henrieta Oravcova et al. Antioxidants
- Systemic and Ocular Adverse Events with Intravitreal Anti-VEGF Therapy Used in the Treatment of Diabetic Retinopathy: a Review
- (2022) Jason A. Zehden et al. Current Diabetes Reports
- Mineralocorticoid interaction with glycated albumin downregulates NRF – 2 signaling pathway in renal cells: Insights into diabetic nephropathy
- (2022) Deepesh D. Gaikwad et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Causal effects of gut microbiota on diabetic retinopathy: A Mendelian randomization study
- (2022) Kangcheng Liu et al. Frontiers in Immunology
- Inflammation in diabetic retinopathy: possible roles in pathogenesis and potential implications for therapy
- (2022) Guo-Tong Xu et al. Neural Regeneration Research
- Current Treatments and Innovations in Diabetic Retinopathy and Diabetic Macular Edema
- (2022) Jesus H. Gonzalez-Cortes et al. Pharmaceutics
- The role of retinal Müller cells in diabetic retinopathy and related therapeutic advances
- (2022) Shuo Yang et al. Frontiers in Cell and Developmental Biology
- Advanced glycation end products in diabetic retinopathy and phytochemical therapy
- (2022) Qingzheng Kang et al. Frontiers in Nutrition
- In-depth transcriptomic analysis of human retina reveals molecular mechanisms underlying diabetic retinopathy
- (2021) Kolja Becker et al. Scientific Reports
- Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
- (2021) Tianqin Wang et al. Eye and Vision
- Glomerular Mesangial Cell pH Homeostasis Mediates Mineralocorticoid Receptor-Induced Cell Proliferation
- (2021) Michael Gekle et al. Biomedicines
- Therapeutic Effects of Fenofibrate Nano-Emulsion Eye Drops on Retinal Vascular Leakage and Neovascularization
- (2021) Li Huang et al. Biology-Basel
- Müller glia-derived exosomal miR-9-3p promotes angiogenesis by restricting sphingosine-1-phosphate receptor S1P1 in diabetic retinopathy
- (2021) Yu Liu et al. Molecular Therapy-Nucleic Acids
- Treatment of diabetic retinopathy through neuropeptide Y‐mediated enhancement of neurovascular microenvironment
- (2020) Kepeng Ou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Targeting the Renin-Angiotensin-Aldosterone System in Fibrosis
- (2020) Mohammad AlQudah et al. MATRIX BIOLOGY
- Hyperoxia induces glutamine-fuelled anaplerosis in retinal Müller cells
- (2020) Charandeep Singh et al. Nature Communications
- The Renin-Angiotensin-Aldosterone System (RAAS) Is One of the Effectors by Which Vascular Endothelial Growth Factor (VEGF)/Anti-VEGF Controls the Endothelial Cell Barrier
- (2020) Yueru Li et al. AMERICAN JOURNAL OF PATHOLOGY
- Aldosterone, Inflammation, Immune System, and Hypertension
- (2020) Nathanne S Ferreira et al. AMERICAN JOURNAL OF HYPERTENSION
- Interrelationship between renin-angiotensin-aldosterone system and oxidative stress in chronic heart failure patients with or without renal impairment
- (2020) Marta Reina-Couto et al. BIOMEDICINE & PHARMACOTHERAPY
- Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
- (2019) Min Zhao et al. Nature Communications
- Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis
- (2019) Jonatan Barrera-Chimal et al. KIDNEY INTERNATIONAL
- The renin‐angiotensin‐aldosterone system and its suppression
- (2019) Marisa K. Ames et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- Fabrication of resveratrol coated gold nanoparticles and investigation of their effect on diabetic retinopathy in streptozotocin induced diabetic rats
- (2019) Yi Dong et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- Recent Development on Detection Methods for the Diagnosis of Diabetic Retinopathy
- (2019) Imran Qureshi et al. Symmetry-Basel
- Angiotensin II and aldosterone in retinal vasculopathy and inflammation
- (2019) Jennifer L. Wilkinson-Berka et al. EXPERIMENTAL EYE RESEARCH
- Aldosterone as a mediator of severity in retinal vascular disease: Evidence and potential mechanisms
- (2019) Michael J. Allingham et al. EXPERIMENTAL EYE RESEARCH
- Endothelial Dysfunction in Primary Aldosteronism
- (2019) Zheng-Wei Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The clinical significance of long non-coding RNA ANRIL level in diabetic retinopathy
- (2019) ShuZe Chen et al. ACTA DIABETOLOGICA
- Angiotensin II and aldosterone activate retinal microglia
- (2019) Indrajeetsinh Rana et al. EXPERIMENTAL EYE RESEARCH
- (Pro)renin receptor: Involvement in diabetic retinopathy and development of molecular targeted therapy
- (2018) Atsuhiro Kanda et al. Journal of Diabetes Investigation
- Worsening diabetic retinopathy with rapid improvement in systemic glucose control: a review
- (2018) Stephen C Bain et al. DIABETES OBESITY & METABOLISM
- Retinopathy and RAAS Activation: Results From the Canadian Study of Longevity in Type 1 Diabetes
- (2018) Julie A. Lovshin et al. DIABETES CARE
- Therapeutic Potentials of Triterpenes in Diabetes and its Associated Complications
- (2016) Swathi Putta et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis
- (2015) Bin Wang et al. Lancet Diabetes & Endocrinology
- Association of ACE and MTHFR genetic polymorphisms with type 2 diabetes mellitus: Susceptibility and complications
- (2014) Ahmad Settin et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Neovascularization Is Attenuated With Aldosterone Synthase Inhibition in Rats With Retinopathy
- (2012) Devy Deliyanti et al. HYPERTENSION
- The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in Müller glial cells
- (2010) Min Zhao et al. FASEB JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search